Statistics for 2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting
Total visits
views | |
---|---|
2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting | 562 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
Einhorn_2017_2016.pdf | 1 |
Top country views
views | |
---|---|
China | 179 |
United States | 174 |
Germany | 16 |
Ukraine | 5 |
United Kingdom | 4 |
Russia | 4 |
Sweden | 3 |
Canada | 2 |
Czechia | 1 |
Greece | 1 |
Malaysia | 1 |
Turkey | 1 |
Top city views
views | |
---|---|
Beijing | 175 |
Wilmington | 47 |
Houston | 19 |
Fairfield | 17 |
Ann Arbor | 16 |
Washington | 15 |
Kiez | 13 |
White Plains | 10 |
Cambridge | 8 |
Jacksonville | 7 |
Kiev | 5 |
Dearborn | 3 |
Lake Mary | 3 |
Overland Park | 3 |
Saint Petersburg | 3 |
San Francisco | 3 |
Stockholm | 3 |
Brooklyn | 2 |
Munich | 2 |
Toronto | 2 |
Abingdon | 1 |
Athens | 1 |
Falls Church | 1 |
Gunzenhausen | 1 |
Indianapolis | 1 |
Istanbul | 1 |
London | 1 |
Moscow | 1 |
Nanjing | 1 |
Philadelphia | 1 |
Seremban | 1 |
Slapanice | 1 |
Zhangzhou | 1 |